Daniel Kachelmyer, PA
Medical · Morristown, TNNPI 1376594317
Payments from drug & device makers
Across 138 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$733
- AbbVie$688
- Johnson & Johnson$466
- Sun Pharmaceutical Industries Inc.$263
- Regeneron Healthcare Solutions, Inc.$202
- Mallinckrodt Hospital Products Inc.$103
- plus $493 from 14 others
What the payments were for
- Food & beverage$2,53086%
- Education$41714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 35 | $733 |
| AbbVie | 39 | $688 |
| Johnson & Johnson | 11 | $466 |
| Sun Pharmaceutical Industries Inc. | 13 | $263 |
| Regeneron Healthcare Solutions, Inc. | 7 | $202 |
| Mallinckrodt Hospital Products Inc. | 4 | $103 |
| UCB, Inc. | 4 | $71 |
| Lilly USA, LLC | 3 | $63 |
| Arcutis Biotherapeutics, Inc. | 4 | $61 |
| Galderma Laboratories, L.p. | 3 | $60 |
| Pfizer | 3 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $32 |
| Sanofi | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| Organon | 3 | $18 |
| Almirall LLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Amgen | 1 | $15 |
How this compares
$2,946 in reported general payments places this provider in the 80th percentile of 480 medical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 27 | $588,191 |
| Humira(Cf) PenAdalimumab | 19 | $211,264 |
| Dupixent PenDupilumab | 12 | $48,581 |
| Clobetasol Propionate | 199 | $9,270 |
| Fluorouracil | 40 | $3,012 |
| Ketoconazole | 109 | $2,182 |
| Fluocinonide | 39 | $1,471 |
| Triamcinolone Acetonide | 149 | $1,393 |
| Betamethasone Valerate | 37 | $1,384 |
| Betamethasone Dipropionate | 22 | $1,315 |
| Terbinafine Hcl | 38 | $562 |
| ValacyclovirValacyclovir Hcl | 20 | $488 |
| Mupirocin | 66 | $486 |
| Hydroxychloroquine Sulfate | 13 | $430 |
| Mometasone Furoate | 17 | $396 |
Paid to pharmacies, not to this prescriber.
Other medical in Morristown
- Ann AyresMorristown$10K
- Lori BlackburnMorristown$6K
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.